📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Combined Vorinostat and Chloroquine Inhibit Sodium-Iodide Symporter Endocytosis and Enhance Radionuclide Uptake In Vivo. (2024)

First Author: Read ML

Attributed to: Next generation molecular imaging and therapy with radionuclides funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1078-0432.ccr-23-2043

PubMed Identifier: 37921808

Publication URI: http://europepmc.org/abstract/MED/37921808

Type: Journal Article/Review

Volume: 30

Parent Publication: Clinical cancer research : an official journal of the American Association for Cancer Research

Issue: 7

ISSN: 1078-0432